FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib

Eligible patients in the expanded access program will be able to receive daraxonrasib from their healthcare provider ...
Healio

Expanded access to daraxonrasib signals ‘dawn of a new era’ in pancreatic cancer treatment

Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut hole.” ...

FDA expands access to pancreatic cancer drug helping patients like Ben Sasse

Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain.
Hosted on MSN

FDA grants expanded access to daraxonrasib for advanced pancreatic cancer

The FDA has authorized expanded access to daraxonrasib, an investigational pan-RAS inhibitor, for patients with pretreated metastatic pancreatic cancer, following trial data showing it nearly doubled ...

FDA authorizes early access for experimental pancreatic cancer pill

The FDA said the action recognizes the dire need for a drug to improve survival for pancreatic cancer patients, who face the ...

F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.